Stock data
CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc. (CNSP) reported net income of -US$15.85M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$15.99M | -US$15.85M | — |
| 2024 | — | — | -US$14.90M | -US$14.86M | — |
| 2023 | — | — | -US$18.87M | -US$18.85M | — |
| 2022 | — | — | -US$15.27M | -US$15.27M | — |
| 2021 | — | — | -US$14.49M | -US$14.50M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$2.59M | — |
| 2026-03-31 | — | -US$4.94M | — |
| 2025-12-31 | — | -US$5.96M | — |
| 2025-09-30 | — | -US$3.22M | — |
| 2025-06-30 | — | -US$2.38M | — |
| 2025-03-31 | — | -US$4.30M | — |
| 2024-12-31 | — | -US$3.18M | — |
| 2024-09-30 | — | -US$5.61M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.